flecainide has been researched along with Central Nervous System Origin Vertigo in 2 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flecainide is an oral class IC antiarrhythmic drug whose most common extracardiac adverse reactions are "dizziness" and "visual disturbances." | 9.22 | A Possible Mechanism for Flecainide Induced Dizziness. ( Garaycochea, O; Manrique-Huarte, R; Pérez-Fernández, N; Riesgo, Á, 2022) |
| "Flecainide is an oral class IC antiarrhythmic drug whose most common extracardiac adverse reactions are "dizziness" and "visual disturbances." | 5.22 | A Possible Mechanism for Flecainide Induced Dizziness. ( Garaycochea, O; Manrique-Huarte, R; Pérez-Fernández, N; Riesgo, Á, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garaycochea, O | 1 |
| Riesgo, Á | 1 |
| Manrique-Huarte, R | 1 |
| Pérez-Fernández, N | 1 |
| Saguner, AM | 1 |
| Vatandaslar, S | 1 |
| Brunckhorst, C | 1 |
1 review available for flecainide and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
A Possible Mechanism for Flecainide Induced Dizziness.
Topics: Aged; Bilateral Vestibulopathy; Dizziness; Flecainide; Head Impulse Test; Humans; Male; Vertigo; Ves | 2022 |
1 other study available for flecainide and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
[CME ECG 40. Vertigo with ST elevation in V2. Brugada syndrome].
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Diagnosis, Differential; Electrocardiography; Emergency Se | 2013 |